Position in ZTS
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$54,241,131
-$12,032,289 QoQ
Shares Held
458,854
-12.9% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Candriam S.C.A. holds $163,728,631 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (33.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
458,854 | $54,241,131 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
63,066 | $37,396,876 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
275,064 | $36,236,931 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,286,841 | $21,770,726 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
467,562 | $14,082,967 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,241,131 | 458,854 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $66,273,420 | 526,732 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $114,765,360 | 784,345 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $92,765,298 | 594,840 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $82,120,998 | 498,761 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $81,198,772 | 498,366 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $108,306,949 | 554,340 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $64,358,165 | 371,240 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $52,674,565 | 311,297 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $41,679,017 | 211,172 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,731,845 | 44,441 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,399,002 | 42,965 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $11,867,504 | 71,302 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,618,305 | 92,926 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,398,674 | 83,611 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,410,121 | 37,292 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $9,727,660 | 51,581 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $12,120,238 | 49,667 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $10,324,365 | 53,180 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $10,029,149 | 53,816 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $5,571,484 | 35,379 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $5,855,224 | 35,379 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $4,992,851 | 30,192 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $4,418,854 | 32,245 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $4,987,937 | 42,382 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||